$KPTI
Karyopharm Therapeutics Inc.

2016 Q4 Form 10-Q Financial Statement

#000119312516761702 Filed on November 07, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $47.00K $48.00K $75.00K
YoY Change 88.0% -36.0% 257.14%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.540M $5.900M $4.760M
YoY Change 24.33% 23.95% 24.93%
% of Gross Profit
Research & Development $20.67M $19.89M $25.92M
YoY Change -14.09% -23.26% 62.52%
% of Gross Profit
Depreciation & Amortization $180.0K $180.0K $170.0K
YoY Change 5.88% 5.88% 70.0%
% of Gross Profit
Operating Expenses $27.21M $25.79M $30.69M
YoY Change -7.21% -15.95% 55.25%
Operating Profit -$27.17M -$25.74M -$30.61M
YoY Change -7.3% -15.9% 55.03%
Interest Expense $360.0K $310.0K $240.0K
YoY Change 44.0% 29.17% 1100.0%
% of Operating Profit
Other Income/Expense, Net $369.0K $317.0K $237.0K
YoY Change 43.58% 33.76% 1085.0%
Pretax Income -$26.80M -$25.43M -$30.37M
YoY Change -7.75% -16.28% 54.01%
Income Tax $140.0K
% Of Pretax Income
Net Earnings -$26.94M -$25.43M -$30.37M
YoY Change -7.27% -16.29% 53.99%
Net Earnings / Revenue -57308.51% -52968.75% -40497.33%
Basic Earnings Per Share
Diluted Earnings Per Share -$650.4K -$690.7K -$850.5K
COMMON SHARES
Basic Shares Outstanding 41.24M shares 35.99M shares 35.71M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $129.6M $126.8M $195.2M
YoY Change -26.2% -35.04% -14.05%
Cash & Equivalents $49.66M $43.91M $43.50M
Short-Term Investments $79.90M $82.90M $151.7M
Other Short-Term Assets $2.100M $3.400M $3.100M
YoY Change 5.0% 9.68% -26.19%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $131.6M $130.3M $198.3M
YoY Change -25.88% -34.33% -14.27%
LONG-TERM ASSETS
Property, Plant & Equipment $2.836M $2.991M $3.660M
YoY Change -18.58% -18.28% 33.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $45.40M $49.60M $34.40M
YoY Change 33.92% 44.19%
Other Assets $500.0K $299.0K $52.00K
YoY Change 0.0% 475.0% -92.3%
Total Long-Term Assets $48.75M $53.37M $38.63M
YoY Change 28.82% 38.17% 914.1%
TOTAL ASSETS
Total Short-Term Assets $131.6M $130.3M $198.3M
Total Long-Term Assets $48.75M $53.37M $38.63M
Total Assets $180.4M $183.6M $237.0M
YoY Change -16.27% -22.51% 0.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.751M $2.193M $4.568M
YoY Change 24.76% -51.99% 117.32%
Accrued Expenses $11.36M $12.31M $9.469M
YoY Change 3.08% 29.99% 159.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.48M $14.95M $14.44M
YoY Change 8.88% 3.55% 131.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.700M $1.700M $1.900M
YoY Change -10.53% -10.53% 72.73%
Total Long-Term Liabilities $1.700M $1.700M $1.900M
YoY Change -10.53% -10.53% 72.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.48M $14.95M $14.44M
Total Long-Term Liabilities $1.700M $1.700M $1.900M
Total Liabilities $18.14M $16.69M $16.38M
YoY Change 6.23% 1.9% 122.81%
SHAREHOLDERS EQUITY
Retained Earnings -$366.1M -$339.2M -$227.5M
YoY Change 42.72% 49.1%
Common Stock $528.6M $506.1M $448.1M
YoY Change 16.14% 12.95% 14936533.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $162.2M $166.9M $220.6M
YoY Change
Total Liabilities & Shareholders Equity $180.4M $183.6M $237.0M
YoY Change -16.27% -22.51% 0.77%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$26.94M -$25.43M -$30.37M
YoY Change -7.27% -16.29% 53.99%
Depreciation, Depletion And Amortization $180.0K $180.0K $170.0K
YoY Change 5.88% 5.88% 70.0%
Cash From Operating Activities -$20.00M -$20.33M -$25.33M
YoY Change -1.86% -19.74% 56.07%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $0.00 -$140.0K
YoY Change -96.08% -100.0% -93.89%
Acquisitions
YoY Change
Other Investing Activities $6.630M -$4.970M $44.69M
YoY Change -80.7% -111.12%
Cash From Investing Activities $6.610M -$4.980M $44.55M
YoY Change -80.47% -111.18% -2045.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.24M 31.48M 40.00K
YoY Change 1200.0% 78600.0% -99.96%
NET CHANGE
Cash From Operating Activities -20.00M -20.33M -25.33M
Cash From Investing Activities 6.610M -4.980M 44.55M
Cash From Financing Activities 19.24M 31.48M 40.00K
Net Change In Cash 5.850M 6.170M 19.26M
YoY Change -60.87% -67.96% -79.69%
FREE CASH FLOW
Cash From Operating Activities -$20.00M -$20.33M -$25.33M
Capital Expenditures -$20.00K $0.00 -$140.0K
Free Cash Flow -$19.98M -$20.33M -$25.19M
YoY Change 0.55% -19.29% 80.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
3681 sqft
CY2014Q4 kpti Operating Lease Scheduled Rent Payments Due
OperatingLeaseScheduledRentPaymentsDue
374000
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39724003 shares
CY2014Q4 kpti Operating Lease Scheduled Rent Payments Due
OperatingLeaseScheduledRentPaymentsDue
420000
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41243412 shares
CY2014Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
29933 sqft
CY2014Q1 us-gaap Security Deposit
SecurityDeposit
400000
CY2014Q1 kpti Estimated Future Security Deposit
EstimatedFutureSecurityDeposit
200000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43499000
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2764000
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
148365000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
62000
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1665000
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39724003 shares
CY2016Q3 us-gaap Assets
Assets
183623000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
98000
CY2016Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1739000
CY2016Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
275000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
130251000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
506125000
CY2016Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
132465000
CY2016Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
70518000
CY2016Q3 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
0 Securities
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43908000
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
4000
CY2016Q3 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
45 Securities
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2193000
CY2016Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
650000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-28000
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
132501000
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12309000
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
175000
CY2016Q3 us-gaap Liabilities
Liabilities
16691000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
183623000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14952000
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
619000
CY2016Q3 us-gaap Long Term Investments
LongTermInvestments
49598000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
299000
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2991000
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4656000
CY2016Q3 us-gaap Short Term Investments
ShortTermInvestments
82903000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
166932000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-339169000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3440000
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
484000
CY2016Q3 kpti Additional Area Included In Operating Sublease After Amendment
AdditionalAreaIncludedInOperatingSubleaseAfterAmendment
16234 sqft
CY2016Q3 kpti Operating Lease Property Leased Area Covered Under Amended Agreement
OperatingLeasePropertyLeasedAreaCoveredUnderAmendedAgreement
27701 sqft
CY2016Q3 kpti Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
8276000
CY2015Q4 us-gaap Liabilities
Liabilities
17078000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150609000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2445000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
200325000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
215000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1128000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35864765 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35864765 shares
CY2015Q4 us-gaap Assets
Assets
215443000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
26000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1946000
CY2015Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
206000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
177600000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
455170000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
151342000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
117851000
CY2015Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
0 Securities
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58358000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2015Q4 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
69 Securities
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3808000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
270000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-282000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
151153000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11023000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
95000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
215443000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15132000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
301000
CY2015Q4 us-gaap Long Term Investments
LongTermInvestments
33878000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3483000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4611000
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
117275000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
198365000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-256527000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1967000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
482000
CY2015Q4 kpti Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
8007000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1343000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-107110000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.51
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16318000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-6000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
457000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-89132000
us-gaap Sales Revenue Net
SalesRevenueNet
225000
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
-771000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
763000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
638000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
262474000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3602000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
386000
us-gaap Operating Expenses
OperatingExpenses
89998000
us-gaap Net Income Loss
NetIncomeLoss
-89135000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-124666000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
138804000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-65000
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
505000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2099000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1080000
us-gaap Operating Income Loss
OperatingIncomeLoss
-89773000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
91216000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
68000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-774000
us-gaap Investment Income Interest
InvestmentIncomeInterest
647000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-73654000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
911000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
85000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
73680000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
5403 shares
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
125000
us-gaap Share Based Compensation
ShareBasedCompensation
11713000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35575745 shares
kpti Restricted Shares Common Stock Vested Value
RestrictedSharesCommonStockVestedValue
111000
kpti Proceeds From Payments For Common Stock Issuance Net
ProceedsFromPaymentsForCommonStockIssuanceNet
90830000
kpti Deferred Financing Costs Included In Accounts Payable
DeferredFinancingCostsIncludedInAccountsPayable
52000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-839000
dei Entity Registrant Name
EntityRegistrantName
KARYOPHARM THERAPEUTICS INC.
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001503802
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14450000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17407000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
35000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
537000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-82388000
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Operating Expenses
OperatingExpenses
83674000
us-gaap Net Income Loss
NetIncomeLoss
-82642000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
17993000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1659000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-412000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
31915000
us-gaap Sales Revenue Net
SalesRevenueNet
107000
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
138000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
859000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
925000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
122681000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1101000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
452000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
225000
us-gaap Investment Income Interest
InvestmentIncomeInterest
926000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
140719000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
29000
us-gaap Operating Income Loss
OperatingIncomeLoss
-83567000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-64393000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000
us-gaap Stock Issued1
StockIssued1
1883000
dei Trading Symbol
TradingSymbol
KPTI
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
66267000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
29724 shares
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
235000
us-gaap Share Based Compensation
ShareBasedCompensation
17157000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36223324 shares
kpti Proceeds From Payments For Common Stock Issuance Net
ProceedsFromPaymentsForCommonStockIssuanceNet
31463000
kpti Rights Received For Each Restricted Share Unit
RightsReceivedForEachRestrictedShareUnit
1 Right
kpti Deferred Financing Costs Included In Accounts Payable
DeferredFinancingCostsIncludedInAccountsPayable
40000
kpti Deferred Financing Costs Included In Accrued Expenses
DeferredFinancingCostsIncludedInAccruedExpenses
258000
CY2014Q4 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P5Y
CY2014Q1 kpti Number Of Additional Lease Terms Option To Renew
NumberOfAdditionalLeaseTermsOptionToRenew
1 Lease
CY2014Q1 kpti Lessee Leasing Arrangements Operating Leases Additional Extension Term
LesseeLeasingArrangementsOperatingLeasesAdditionalExtensionTerm
P5Y
CY2015Q1 kpti Operating Leases Allowance For Improvements
OperatingLeasesAllowanceForImprovements
1616000
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4762000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30255000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
75000
CY2015Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
299000
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
237000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
30685000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-30373000
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-30610000
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
110000
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
239000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25923000
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35708739 shares
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5897000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25592000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
48000
CY2016Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
280000
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
317000
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
25790000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-25425000
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25742000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-182000
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
311000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19893000
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36819329 shares

Files In Submission

Name View Source Status
0001193125-16-761702-index-headers.html Edgar Link pending
0001193125-16-761702-index.html Edgar Link pending
0001193125-16-761702.txt Edgar Link pending
0001193125-16-761702-xbrl.zip Edgar Link pending
d191992d10q.htm Edgar Link pending
d191992dex311.htm Edgar Link pending
d191992dex312.htm Edgar Link pending
d191992dex321.htm Edgar Link pending
d191992dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kpti-20160930.xml Edgar Link completed
kpti-20160930.xsd Edgar Link pending
kpti-20160930_cal.xml Edgar Link unprocessable
kpti-20160930_def.xml Edgar Link unprocessable
kpti-20160930_lab.xml Edgar Link unprocessable
kpti-20160930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending